A nomogram to predict survival in non-small cell lung cancer patients treated with nivolumab

BACKGROUND: The advent of immune checkpoint inhibitors (ICIs) has considerably expanded the armamentarium against non-small cell lung cancer (NSCLC) contributing to reshaping treatment paradigms in the advanced disease setting. While promising tissue- and plasma-based biomarkers are under investigat...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:J Transl Med
Main Authors: Botticelli, Andrea, Salati, Massimiliano, Di Pietro, Francesca Romana, Strigari, Lidia, Cerbelli, Bruna, Zizzari, Ilaria Grazia, Giusti, Raffaele, Mazzotta, Marco, Mazzuca, Federica, Roberto, Michela, Vici, Patrizia, Pizzuti, Laura, Nuti, Marianna, Marchetti, Paolo
Formato: Artigo
Idioma:Inglês
Publicado em: BioMed Central 2019
Assuntos:
Research
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC6437908/
https://ncbi.nlm.nih.gov/pubmed/30917841
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s12967-019-1847-x
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados